The upgrade from Sell to Neutral indicates a more positive outlook on Alvotech by Citigroup. The doubling of the price target from $5 to $10 suggests that the analyst sees significant upside potential for the stock. This could lead to increased investor interest and potentially a short-term increase in the stock price.